These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 20821217)
1. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217 [TBL] [Abstract][Full Text] [Related]
2. Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer. Hayama T; Hashiguchi Y; Okada Y; Ono K; Nemoto K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K Int J Colorectal Dis; 2020 Jan; 35(1):119-124. PubMed ID: 31797097 [TBL] [Abstract][Full Text] [Related]
3. Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer. Maruyama T; Shimoda M; Hakoda H; Sako A; Ueda K; Suzuki S Am J Surg; 2021 Jul; 222(1):179-185. PubMed ID: 33138968 [TBL] [Abstract][Full Text] [Related]
4. [Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy]. Li J; Jia YB; Cai CN; Guan XD; Li PP; Xie YY; Zhang BM Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1171-4. PubMed ID: 23172532 [TBL] [Abstract][Full Text] [Related]
5. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study. Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206 [TBL] [Abstract][Full Text] [Related]
8. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte. Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849 [TBL] [Abstract][Full Text] [Related]
9. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Malietzis G; Giacometti M; Askari A; Nachiappan S; Kennedy RH; Faiz OD; Aziz O; Jenkins JT Ann Surg; 2014 Aug; 260(2):287-92. PubMed ID: 24096764 [TBL] [Abstract][Full Text] [Related]
10. Elevated tumor-to-liver uptake ratio (TLR) from Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134 [TBL] [Abstract][Full Text] [Related]
11. A prognostic model to predict survival in stage III colon cancer patients based on histological grade, preoperative carcinoembryonic antigen level and the neutrophil lymphocyte ratio. Wuxiao ZJ; Zhou HY; Wang KF; Chen XQ; Hao XB; Lu YD; Xia ZJ Asian Pac J Cancer Prev; 2015; 16(2):747-51. PubMed ID: 25684519 [TBL] [Abstract][Full Text] [Related]
12. The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features. Erdur E; Yildirim OA; Poyraz K; Aslan F; Yıldız F; Kömek H Postgrad Med; 2021 Aug; 133(6):694-700. PubMed ID: 34030576 [TBL] [Abstract][Full Text] [Related]
13. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242 [TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer. Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672 [TBL] [Abstract][Full Text] [Related]
17. [An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer]. Urrejola GI; Bambs CE; Espinoza MA; Gellona J; Zúñiga AM; Molina ME; Bellolio F; Miguieles R; Campbell JM; Pinedo GA Rev Med Chil; 2013 May; 141(5):602-8. PubMed ID: 24089275 [TBL] [Abstract][Full Text] [Related]
18. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma. Sun J; Ning H; Sun J; Qu X Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433 [TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035 [TBL] [Abstract][Full Text] [Related]
20. Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner. Urabe M; Yamashita H; Uemura Y; Tanabe A; Yagi K; Aikou S; Seto Y Jpn J Clin Oncol; 2018 Apr; 48(4):343-349. PubMed ID: 29420755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]